Showing 611 articles

  • TISSIUM Announces Appointment of Independent Board Member

    15 Dec 2020| Mike Wood

    TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today that Michel Thérin has been appointed to the Company’s Board of Directors. 

  • Rexgenero Appoints Sadia L’Baouch as Chief Manufacturing Officer

    9 Dec 2020| Nola Cadman

    Sadia has an MSc in Chemical Engineering from the University of Compiégne, France, and an MBA in Business Administration from Warwick University, UK. She is an AIM Accredited Change Manager, and an IChemE Chartered Chemical Engineer.

  • SeraNovo Appoints Michiel Van Speybroeck as Chief Development Officer as Lead Programs Progress Through Clinical Studies

    8 Dec 2020| Nola Cadman

    SeraNovo, a pharmaceutical company with a breakthrough proprietary formulation platform for enhancing drug bioavailability has appointed Dr Michiel Van Speybroeck to the role of Chief Development Officer (CDO) with immediate effect.

  • Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer

    8 Dec 2020| Nola Cadman

    Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells.

  • Cherwell appoints Director of Sales to support continued company growth and future customer needs

    8 Dec 2020| Nola Cadman

    Emma Millburn brings a wealth of experience in strategic planning to newly created leadership role

  • PharmiWeb.Jobs Welcomes Experis

    4 Dec 2020| Nola Cadman

    PharmiWeb Jobs is delighted to Welcome Experis

  • Pharma.Aero welcomes 3 new Full Members – First Priority Cargo, BDP International and SAASA

    2 Dec 2020| Nola Cadman

    Pharma.Aero enlarges its membership base with three new Full members – Dubai-based logistics and transportation services company First Priority Cargo, global 4PL BDP International and Lima-based ground handler SAASA (Servicios Aeroportuarios Andinos S.A). Over the course of the last two months, Pharma.Aero has onboarded a total of 8 new members.

  • Hofseth Biocare ASA: Boosts Sales & Marketing in its Consumer Health division by hiring ex-Novartis and ex-GSK senior executive Andy Gill

    2 Dec 2020| Nola Cadman

    HBC is delighted to announce the hiring of Andy Gill as VP within HBC’s Consumer Health Division from January 2021. Mr Gill is a highly accomplished commercial leader with over 20 years’ experience in driving growth in the Healthcare and FMCG industries.

  • Should We Encourage Longer Lunch breaks?

    1 Dec 2020| Mike Wood

    Longer lunch breaks could make a happier and more productive team.

  • PharmiWeb.Jobs Welcomes Upsilon Global

    30 Nov 2020| Nola Cadman

    Upsilon Global is a clinical research partnership that specialise in supporting CROs, Biotechs, Pharmaceuticals and Medical Device companies with clinical studies.

  • Sensyne Health appoints President, North America, to lead US expansion

    27 Nov 2020| Nola Cadman

    Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange

  • Congenica Appoints Dr. Sam Roberts as Non-Executive Director

    27 Nov 2020| Nola Cadman

    Sam originally trained as a medical doctor, followed by several management consulting roles, including at McKinsey. She holds an MBA from the Australian Graduate School of Management and a DPhil in Evidence Based Healthcare from the University of Oxford.

  • PureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors

    27 Nov 2020| Nola Cadman

    Mr. Ignelzi brings strong financial and operational expertise to the board and will serve as chairman of the Audit Committee

  • PharmiWeb.Jobs Welcomes Porton Biopharma

    13 Nov 2020| Nola Cadman

    Porton Biopharma has approximately 400 staff in a wide range of roles from those working in our pharmaceutical manufacturing plants, through to our quality and scientific development groups. All focused on developing & manufacturing life-saving products that make a real difference to patients’ lives.

  • The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy

    13 Nov 2020| Nola Cadman

    The Sputnik V vaccine efficacy amounted to 92% (calculation based on the 20 confirmed COVID-19 cases split between vaccinated individuals and those who received the placebo).

  • Coulter Partners announces new appointments in the US, London and Denmark

    12 Nov 2020| Nola Cadman

    Coulter Partners is a board and senior level specialist executive search firm focussed exclusively on global Life Sciences. From our offices in the UK, Europe, North America and Asia-Pacific

  • Intravacc appoints Prof. Dr. Virgil Schijns as Chief Scientific Officer

    12 Nov 2020| Nola Cadman

    Intravacc, based at the Utrecht Science Park Bilthoven in The Netherlands, is a leading global organization with many years of experience in translational vaccinology.

  • UK ostomy business appoints industry leader as non-executive director

    12 Nov 2020| Nola Cadman

    Trio Healthcare was founded in 2006 and CEO Lloyd Pearce has been with the business since the start. A leader in stoma care, the company focuses on addressing the unmet needs of ostomates around the world, improving quality of life with its advanced healthcare technology. Trio, which won the Queen’s Award for Enterprise 2011 and 2018, hold patents for a novel silicone-based breathable technology, developed to be gentler to the skin and reduce healthcare spending.

  • Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates

    12 Nov 2020| Nola Cadman

    Novavax, Inc. (Nasdaq: NVAX) is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases